MODIFICATION OF APEXPRO TELEMETRY SYSTEM

K021325 · General Electric Medical Systems Information Techn · MHX · May 7, 2002 · Cardiovascular

Device Facts

Record IDK021325
Device NameMODIFICATION OF APEXPRO TELEMETRY SYSTEM
ApplicantGeneral Electric Medical Systems Information Techn
Product CodeMHX · Cardiovascular
Decision DateMay 7, 2002
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 870.1025
Device ClassClass 2

Intended Use

The ApexPro Telemetry System is intended for use under the direct supervision of a licensed healthcare practitioner. The system is designed to acquire and monitor physiological data for ambulating patients within a defined coverage area. The system processes this physiological data to detect various ECG arrhythmia events and select physiological parameter limit violations. The ApexPro Telemetry System is intended to be installed in the hospital or clinical environment in order to provide clinicians with patient physiological data, while allowing for patient mobility. These systems are typically deployed in sub acute care areas in hospitals or clinical sites where patient mobility can enhance the effectiveness of the medical procedures administered. The physiological parameters monitored include ECG, non-invasive blood pressure and SpO2. The ApexPro Telemetry System is intended to provide ECG data via Ethernet to the computer platform for processing. The ApexPro is also intended to provide physiologic data over the Unity network to clinical information systems for display.

Device Story

ApexPro Telemetry System acquires physiological data (ECG, SpO2, non-invasive blood pressure) from patient-worn transmitters; transmits data via RF to receiver infrastructure; processes signals on a computer platform running ApexPro Telemetry Application. System detects ECG arrhythmia events and physiological parameter limit violations. Used in hospital/clinical sub-acute care areas; operated by clinicians. Output displayed on central station applications and clinical information systems via Unity network. Enables patient mobility while maintaining continuous monitoring; assists clinicians in patient management and medical procedure effectiveness.

Clinical Evidence

No clinical data. Bench testing only; system validation performed via requirements specification review, code inspections, software/hardware testing, safety testing, and environmental testing.

Technological Characteristics

System components: patient-worn transmitters, receiver antenna infrastructure, receivers, receiver subsystem, computer platforms. Connectivity: Ethernet for ECG data, Unity network for clinical information system integration. Signal processing and RF components updated for performance/integration. Software-based arrhythmia detection and parameter limit monitoring.

Indications for Use

Indicated for ambulating patients in hospital or clinical sub-acute care settings requiring continuous monitoring of ECG, non-invasive blood pressure, and SpO2 under direct supervision of a licensed healthcare practitioner.

Regulatory Classification

Identification

The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs.

Special Controls

*Classification.* Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ # MAY 0 7 2002 K021325 page 1 of 2 ## 510(k) Summary of Safety and Effectiveness ﺑ , : | Date: | April 19, 2002 | |-----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Submitter: | GE Medical Systems Information Technologies<br>8200 West Tower Avenue<br>Milwaukee, WI 53223 USA | | Contact Person: | Joelle Neider<br>Regulatory Affairs Specialist<br>GE Medical Systems Information Technologies<br>Phone: 203-949-8232<br>Fax: 414-918-8113 | | Device:<br> | | | Trade Name: | ApexPro Telemetry System | | Common/Usual Name: | Telemetry Monitoring System | | Classification Names: | 21 CFR 870.1025 Detector and Alarm, Arrhythmia<br>21 CFR 870.2910 Transmitters & Receivers, Physiological Signal, Radio Frequency | | Predicate Device: | K000779 ApexPro Telemetry System | | Device Description: | The ApexPro Telemetry System is composed of six major components:<br>• The patient worn data acquisition transmitters<br>• The receiver antenna system infrastructure<br>• The receivers<br>• The receiver subsystem<br>• A computer platform running the ApexPro Telemetry Application<br>• A computer platform running a central station application (which may be the same computer platform running the ApexPro Telemetry Application) | | Intended Use: | The ApexPro Telemetry System is intended for use under the direct supervision of a licensed healthcare practitioner. The system is designed to acquire and monitor physiological data for ambulating patients within a defined coverage area. The system processes this physiological data to detect various ECG arrhythmia events and select physiological parameter limit violations.<br><br>The ApexPro Telemetry System is intended to be installed in the hospital or clinical environment in order to provide clinicians with patient physiological data, while allowing for patient mobility. These systems are typically deployed in sub acute care areas in hospitals or clinical sites where patient mobility can enhance the effectiveness of the medical procedures administered.<br><br>The physiological parameters monitored include ECG, non-invasive blood pressure and SpO2. The ApexPro Telemetry System is intended to provide ECG data via Ethernet to the computer platform for processing. The ApexPro is also intended to provide physiologic data over the Unity network to clinical information systems for display. | | Technology: | The ApexPro employs the same functional technology as the predicate devices. The system architecture has taken advantage of improvements in signal processing technology as well as advances in RF component technologies to improve performance and level of integration. | {1}------------------------------------------------ K021325 page 2 of 2 Test Summary: The ApexPro complies with the voluntary standards as detailed in The following quality assurance Section 9 of this submission. measures were applied to the development of the system: - Requirements specification review ● - Code inspections . - Software and hardware testing ● - Safety testing . - Environmental testing . - Final validation . - The results of these measurements demonstrated that the ApexPro Conclusion: THE Toodite of thous effective, and performs as well as the predicate devices. {2}------------------------------------------------ #### DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 ### MAY 0 7 2002 Ms. Joelle Neider Regulatory Affairs Specialist GE Medical Systems Information Technologies 8200 West Tower Avenue Milwaukee, WI 53223 Re: K021325 Trade Name: ApexPro Telemetry System Regulation Number: 21 CFR 870.1025 Regulation Name: Arrhythmia Detector and Alarm Regulatory Class: Class III (three) Product Code: MHX Dated: April 22, 2002 Received: April 26, 2002 Dear Ms. Neider: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ #### Page 2 - Ms. Joelle Neider Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4646. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, Dak Tiller Ph.D. Donna-Bea Tillman, Ph.D. Acting Director Division of Cardiovascular and Respiratory Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ Page 1 of 1 510(k) Number (if known): 510(k) filed on April 19, 2002 Device Name: ApexPro Telemetry System Indications For Use: The ApexPro Telemetry System is intended for use under the direct supervision of a licensed healthcare practitioner. The system is designed to acquire and monitor physiological data for noulating patients within a defined coverage area. The system processes this physiological data to detect various ECG arrhythmia events and select physiological parameter limit violations. The ApexPro Telemetry System is intended to be installed in the hospital or clinical environment in order to provide clinicians with patient physiological data, while allowing for patient mobility. These systems are typically deployed in sub acute care areas in hospitals or clinical sites where patient mobility can enhance the effectiveness of the medical procedures administered. The physiological parameters monitored include ECG, non-invasive blood pressure and SpO2 The ApexPro Telemetry System is intended to provide ECG data via Ethernet to the computer platform for processing. The ApexPro is also intended to provide physiologic data over the Unity network to clinical information systems for display. (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use 7 (Per 21 CFR 801.109) OR Over-The-Counter Use (Optional Format 1-2-96) Division of Cardiovascular & Respiratory Devices 510(k) Number K021325
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%